Riskpilot← Back to searchSign inGet full accessDoktor Werachanya AB
ABActiveOrg 5567917017Västergatan 13Hospital activities · NACE 8610Est. 20090 employees
Revenue 2025
SEK 2,3M
+8% vs 2024
EBITDA margin
45.0%
+34% vs 2024
Equity ratio
29.0%
Financial strength
Net profit 2025
SEK 636K
+33% vs 2024
| Revenue | SEK 2,3M | +8% |
| EBITDA | SEK 1,1M | +34% |
| Net profit | SEK 636K | +33% |
| Total assets | SEK 2,6M | +26% |
| Equity | SEK 758K | +22% |
| Employees | 0 | — |
Legal name
Doktor Werachanya AB
Org number
5567917017
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
27 oktober 2009
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva läkartjänster och hälsovård och därmed förenlig verksamhet.
Address
Västergatan 13
Phone
+46417511483
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 736 | 1 613 | 1 703 | 2 178 | 2 346 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 684 | 328 | 374 | 786 | 1 056 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 684 | 328 | 374 | 786 | 1 056 |
| Net financials | — | −1 | −1 | 14 | 19 |
| Profit before tax | 514 | 248 | 283 | 604 | 805 |
| Tax | −110 | −52 | −60 | −127 | −169 |
| Net profit | 404 | 196 | 223 | 477 | 636 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 677 | 1 420 | 1 423 | 2 071 | 2 618 |
| Equity | 526 | 321 | 344 | 621 | 758 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 822 | 689 | 579 | 755 | 895 |
| Total debt | 822 | 689 | 579 | 755 | 895 |
EBITDA margin
45.0%
This company
15.8%
Market median
+185% vs market
20212025
Equity ratio
29.0%
This company
38.2%
Market median
-24% vs market
20212025
Return on equity
83.9%
This company
18.4%
Market median
+356% vs market
20212025
Net profit margin
27.1%
This company
8.1%
Market median
+235% vs market
20212025
Asset turnover
0.90×
This company
1.12×
Market median
+20% vs market
20212025
Debt / equity
2.45×
This company
0.62×
Market median
-295% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
IC Authorized Recipient of Service | Authorized Recipient of Service | 2024 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doktor Werachanya AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inger Christine Lundmark | Authorized Recipient of Service | 0 companies |
| Valerija Beitina | Deputy Board Member | 0 companies |
| Lilia Ismaguilova Werachanya | Board of Directors | 0 companies |